Method for treating chronic pain using MEK inhibitors

Details Method for treating chronic pain using MEK inhibitors Method for treating chronic pain using MEK inhibitors

2006-04-18

2006-04-18

Hui, San-Ming (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S359000, C514S361000, C514S362000, C514S367000

Reexamination Certificate

active

07030119

ABSTRACT:
The invention features a method for treating chronic pain using a compound of formula (I).

REFERENCES:
patent: 5155110 (1992-10-01), Connor et al.
patent: 6469004 (2002-10-01), Barrett et al.
patent: WO 98/37881 (1998-09-01), None
patent: WO 00/35436 (2000-06-01), None
patent: WO 00/42022 (2000-07-01), None
Alessi, Dario R., et al., “PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo”, J. Biol. Chem., 1995, pp 27489-27494, vol. 270, No. 46.
Hwang, Daniel, et al., “Expression of Mitogen-Inducible Cyclooxygenase Induced by Lipopolysaccharide: Mediation through both mitogen-activated protein kinase and NF-KB signaling pathways in macrophages”, Biochem Pharm, 1997, pp 87-96, vol. 54, Issue 1.
Larrivee, Jean-François, et al., “Role of the Mitogen-Activated Protein Kinases in the Expression of the Kinin B1 Receptors Induced by Tissue Injury ”, J Immunol, 1998, pp 1419-1426, vol. 160, No. 3.
Polakiewicz, Roberto D., et al., “A Mitogen-activated Protein Kinase Pathway Is Required for μ-Opioid Receptor Desensitization”, J. Biol. Chem., 1998, pp 12402-12406. vol. 273, No. 20.
PCT International Search Report PCT/US00/18345.
H. Bekemeier, et al., “Structure-Activity Relationship in Nonsteroidal Antinflammatory Agents, Including Qsar in Fenamate Derivatives”, Agents and Actions Supplements, Jul. 1, 1982, pp 17-34.
J. V. Duncia, et al., “MEK Inhibitors: The Chemistry and Biological Activity of U0126, Its Analogs, and Cyclization Products”, Bioorganic & Medicinal Chemistry Letters, 1998, pp 2839-2844, No. 8.
N. S. Duesbery, et al., “MEK Waars, a new front in the Battle Against Cancer”, Nature Medicine, Jul. 1999, pp 736-737, vol. 5, No. 7.
Ru-Rong Ji, et al., “Nociceptive-specific Activation of ERK in Spinal Neurons Contributes to Pain Hypersensitivity”, Nature Neuroscience, Dec. 1999, pp 1114-1119, vol. 2, No. 12.
Office Action for 10/031,149 (A0000104-01-SMH) dated May 11, 2005.

Affiliated with

Also associated with

Rating

Method for treating chronic pain using MEK inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating chronic pain using MEK inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating chronic pain using MEK inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3531197